Clinical trial Recruiting at 2 sites Interventional Ages 18 and up Women only

Effects of metabolic health patterns on breast cancer outcomes in women

Official title: Impact of Metabolic Health Patterns And Breast Cancer Over Time in Women

Run by University of Alberta · NCT05432856 · Data updated 2026-11-12

This study is testing whether improving metabolic health through diet and activity changes can help women with breast cancer feel better and reduce their heart disease risk during and after chemotherapy.

More Cardiovascular Diseases trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexWomen only
Enrollment65 (estimated)
SponsorUniversity of Alberta
Academic / other
Drugs / interventionschemotherapy
Locations2 sites (Edmonton, Alberta and 1 other locations)
StatusRecruiting
StartedMarch 13, 2024
Main results expectedDecember 2028
Study endsDecember 2028
Registry record updatedJuly 20, 2026
Trial IDNCT05432856 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are women over 18 years old, diagnosed with stage I, II, or III breast cancer, and starting chemotherapy.

Probably not a fit

Patients with uncontrolled diabetes requiring insulin, significant thyroid disorders, or a history of eating disorders may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the impact of metabolic health patterns on breast cancer outcomes over time in women undergoing chemotherapy. It focuses on the relationship between breast cancer treatment, cardiovascular disease risk, and metabolic changes such as insulin resistance and dyslipidemia. Participants will engage in interventions including time-restricted eating, nutrition education, and strategies to reduce sedentary time. The goal is to understand how these interventions can improve metabolic health and reduce cardiovascular risks in breast cancer survivors.

Why it matters

Potential benefit: If successful, this study could lead to improved metabolic health and reduced cardiovascular risks for women undergoing treatment for breast cancer.

How similar studies have gone: Other studies have shown promising results in improving metabolic health and reducing cardiovascular risks in cancer survivors through lifestyle interventions.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Female biological sex at birth
* \>18 years
* Diagnosis of stage I, II, or III breast cancer
* starting neoadjuvant or adjuvant intravenous chemotherapy
* ECOG \<3;
* Oncologist approval to participate;
* English speaking (all study materials and study staff will be in English)
* Willing and able to adhere to study intervention

Exclusion Criteria:

* Individuals who do not have access to a smart phone with Bluetooth capability (required for Fitbit and for responding to intervention text messages) or at least a shared cell phone with someone in the same household (i.e., some couples may share a phone).
* Type 1 or type 2 diabetes who require exogenous insulin (due to the potential need to adjust insulin dosing with TRE) or with hemoglobin A1c \>10%
* Research MRI contraindications (e.g., pacemaker, magnetic implants, pregnancy)
* Uncontrolled thyroid disorder
* Self-reported eating disorder history
* Body mass index \<18.5 kg/m2 or clinical signs of cachexia (discretion of treating oncologist)
* ≥5% body weight loss within last 6 months
* Those who are currently working night/rotating shifts, eating within ≤10-hour window or consistently eating less than 3 meals/day in the past 3 months.
* patients who meet the criteria for medical clearance prior to exercise using the Physical Activity Readiness Questionnaire+ and are not cleared by their treating oncologist or family physician to perform maximal exercise testing.

Where it's running

  • University of Alberta
    Edmonton, Alberta, Canada
    Recruiting
  • University of Toronto
    Toronto, Ontario, Canada
    Recruiting

Study contacts

  • Principal investigator: Richard Thompson, PhD — University of Alberta
  • Study coordinator: Rachel Sherrington, Bkin
  • Email: rsherrin@ualberta.ca
  • Phone: 780-668-1669

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.